GLRX5 and infection: In recent years, a great number of candidate antigen proteins for a S. suis subunit vaccine have been identified, among which the immunoglobulin M-degrading enzyme (IdeSsuis) [30] and peptidyl isomerase (PrsA) [31] have been reported to provide cross-protection against SS2 and SS9 infections.